Is ZTS Worth Buying in 2026?

ZOETIS INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether ZOETIS INC. (ZTS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: above the 50-day MA (medium-term momentum positive); RSI 51 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-1.02% over 10 days); weak 1-year return of -50.0%. Currently 51.1% off its 52-week high. Score: -2/7.

Ready to act on this? 📈 Trade on Webull

ZTS is trading below its 200-day MA ($105.24) — a key warning sign the longer-term trend is under pressure. An RSI of 51.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -50.0% compares to +20.5% for SPY (trailed the market by 70.5%). The current 51.1% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $4,995 today
vs. S&P 500 (SPY) — same period trailed market by 70.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($105.24)
Above 50-day MA ($75.94)
RSI(14) neutral zone (30–70) — currently 51.1
Positive return (-50.0%)
!Within 10% of period high (−51.1%)
Period Range $77.73
$71.00 $159.00
RSI (14) 51.1
0 · OversoldOverbought · 100

Key Metrics

Price$77.73
Period Return-50.0%
Period High$159.00
Period Low$71.00
Drawdown−51.1%
MA-50$75.94
MA-200$105.24
RSI (14)51.1
Avg Volume (30d)6.5M
vs. SPYtrailed by 70.5%
Return Rank#900 of 999

Trade ZTS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers